Medifast (FRA:MDF) Cyclically Adjusted PS Ratio: (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MDF Medifast Inc FRA:MDF
63 GF Score
Price €11.18
GF Value €7.31
! 2 Warning Signs
View Full Analysis

What is Medifast Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medifast  (FRA:MDF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medifast Cyclically Adjusted PS Ratio Related Terms


Medifast Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Medifast's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast Cyclically Adjusted PS Ratio Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.27 1.82 0.93 0.23 0.13

Medifast Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.17 0.13 0.13 0.00

FRA:MDF vs RGS, CLIK, EVTK: Cyclically Adjusted PS Ratio Comparison

For the Personal Services subindustry, Medifast's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Cyclically Adjusted PS Ratio vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's Cyclically Adjusted PS Ratio falls into.


FRA:MDF
63GF Score
Medifast Inc FRA:MDF
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medifast's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Medifast's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.954/333.9520*333.9520
=5.954

Current CPI (Jun. 2026) = 333.9520.

Medifast Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 5.114 241.428 7.074
201612 4.930 241.432 6.819
201703 5.499 243.801 7.532
201706 5.590 244.955 7.621
201709 5.356 246.819 7.247
201712 5.419 246.524 7.341
201803 6.587 249.554 8.815
201806 8.249 251.989 10.932
201809 9.864 252.439 13.049
201812 10.701 251.233 14.224
201903 11.993 254.202 15.756
201906 13.553 256.143 17.670
201909 14.304 256.759 18.604
201912 12.855 256.974 16.706
202003 13.659 258.115 17.672
202006 16.526 257.797 21.408
202009 19.438 260.280 24.940
202012 18.330 260.474 23.501
202103 24.086 264.877 30.367
202106 27.591 271.696 33.913
202109 29.816 274.310 36.299
202112 28.502 278.802 34.140
202203 32.581 287.504 37.845
202206 37.504 296.311 42.268
202209 35.709 296.808 40.178
202212 28.950 296.797 32.574
202303 29.906 301.836 33.088
202306 25.042 305.109 27.409
202309 20.215 307.789 21.933
202312 16.057 306.746 17.481
202403 14.671 312.332 15.687
202406 14.317 314.175 15.218
202409 11.511 315.301 12.192
202412 10.355 315.605 10.957
202503 9.778 319.799 10.211
202506 8.275 322.561 8.567
202509 6.931 324.800 7.126
202512 5.834 324.054 6.012
202603 5.977 330.213 6.045
202606 5.954 333.952 5.954

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medifast (FRA:MDF) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of €11.18 is trading 52.9% above its estimated GF Value™ of €7.31.

Key valuation signals for FRA:MDF:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €7.31 vs. price of €11.18 (52.9% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
63GF Score

Get the complete analysis for FRA:MDF

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.18
Price
€7.31
GF Value